A5HZZ5 (A5HZZ5_CLOBH) Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A)

Hemagglutinin component of the neurotoxin complex UniProtKBInterProInteractive Modelling

146 aa; Sequence (Fasta) ; 3 identical sequences: Clostridium botulinum: A0A3F2ZS81, Q45878; Clostridium botulinum CFSAN001627: M1ZNV3

Available Structures

9 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Apo HA17-HA33 Heteromer
Q45871; Q45878;
3-146
Assess
Crystal structure of HA17-HA33-IPT Heteromer
Q45871; Q45878;
IPT;3-146
Assess
HA17-HA33-LacNac Heteromer
Q45871; Q45878;
NDG;3-146
Assess
HA17-HA33-Gal Heteromer
Q45871; Q45878;
GAL;3-146
Assess
HA17-HA33-Lac Heteromer
Q45871; Q45878;
BGC;3-146
Assess
Crystal structure of HA17-HA33-Lactulose Heteromer
Q45871; Q45878;
FRU;3-146
Assess
HA70(D3)-HA17 Heteromer
Q45878; Q8KHU9;
4-146
Assess
Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex Heteromer
A5HZZ4; A5HZZ6; P09803;
CA;4-146
Assess
HA70(D3)-HA17-HA33 Heteromer
Q45871; Q45878; Q8KHU9;
8-146
Assess

Alignments